Marvel Biosciences Corp Market Cap ($5.04 Million)
Market Cap & Net Worth: Marvel Biosciences Corp (MRVL)
Marvel Biosciences Corp market cap. Marvel Biosciences Corp (V:MRVL) has a market capitalization of $5.04 Million (CA$6.96 Million) as of November 1, 2026. Listed on the V stock exchange, this Canada-based company holds position #28518 globally and #1247 in its home market, demonstrating a 4.35% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Marvel Biosciences Corp's stock price CA$0.12 by its total outstanding shares 58004481 (58.00 Million). Also see MRVL cash flow conversion for how efficiently the company converts equity into cash flow.
Marvel Biosciences Corp Market Cap History (2021–2026)
Marvel Biosciences Corp market cap history from 2021 to 2026. Data shows change from $11.33 Million to $5.04 Million (-19.93% CAGR). Check MRVL stock price for real-time trading data and today's change.
Marvel Biosciences Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Marvel Biosciences Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Marvel Biosciences Corp net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of MRVL by Market Capitalization
Companies near Marvel Biosciences Corp in the global market cap rankings as of November 1, 2026. Also see Marvel Biosciences Corp asset portfolio for a full breakdown of the balance sheet.
Key companies related to Marvel Biosciences Corp by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #182 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #371 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #412 globally with a market cap of $68.91 Billion USD ( AU$97.38 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #495 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #182 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $558.88 |
| #371 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $927.89 |
| #412 | CSL Ltd | AU:CSL | $68.91 Billion | AU$200.73 |
| #495 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $221.72 |
Market Capitalization of Marvel Biosciences Corp (2021–2026)
Market capitalization of Marvel Biosciences Corp from 2021 to today. Between 2021 and today, Marvel Biosciences Corp's market cap moved from $11.33 Million to $ 5.04 Million, with a yearly change of -19.93%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CA$5.04 Million | -11.11% |
| 2025 | CA$5.66 Million | -20.59% |
| 2024 | CA$7.13 Million | +112.50% |
| 2023 | CA$3.36 Million | -36.00% |
| 2022 | CA$5.24 Million | -53.70% |
| 2021 | CA$11.33 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Marvel Biosciences Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.04 Million USD |
| MoneyControl | $5.04 Million USD |
| MarketWatch | $5.04 Million USD |
| marketcap.company | $5.04 Million USD |
| Reuters | $5.04 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Marvel Biosciences Corp
Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The company's lead compound MB-204, a novel fluorinated derivative of istradefylline, an adenosine A2a receptor antagonist to treat alzheimer's disease and autism spectrum disorder, as well as depression and anxiety. It provides non-hal… Read more